
Delia M. Ramirez
Examiner (ID: 4462)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1518 |
| Issued Applications | 818 |
| Pending Applications | 200 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20414330
[patent_doc_number] => 12497603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Cas effector proteins, gene editing systems, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/957929
[patent_app_country] => US
[patent_app_date] => 2024-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 27
[patent_no_of_words] => 14619
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18957929
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/957929 | NOVEL CAS EFFECTOR PROTEINS, GENE EDITING SYSTEMS, AND USES THEREOF | Nov 24, 2024 | Issued |
Array
(
[id] => 20414330
[patent_doc_number] => 12497603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Cas effector proteins, gene editing systems, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/957929
[patent_app_country] => US
[patent_app_date] => 2024-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 27
[patent_no_of_words] => 14619
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18957929
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/957929 | NOVEL CAS EFFECTOR PROTEINS, GENE EDITING SYSTEMS, AND USES THEREOF | Nov 24, 2024 | Issued |
Array
(
[id] => 20149244
[patent_doc_number] => 20250249082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-07
[patent_title] => TARGETED THROMBOLYSIS FOR TREATMENT OF MICROVASCULAR THROMBOSIS
[patent_app_type] => utility
[patent_app_number] => 18/829591
[patent_app_country] => US
[patent_app_date] => 2024-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18829591
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/829591 | TARGETED THROMBOLYSIS FOR TREATMENT OF MICROVASCULAR THROMBOSIS | Sep 9, 2024 | Pending |
Array
(
[id] => 19389760
[patent_doc_number] => 20240279630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => ISOLATED CAS13 PROTEIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/652819
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652819
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652819 | ISOLATED CAS13 PROTEIN AND USE THEREOF | May 1, 2024 | Pending |
Array
(
[id] => 19543392
[patent_doc_number] => 20240360428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/631568
[patent_app_country] => US
[patent_app_date] => 2024-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631568
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/631568 | DNA modifying enzymes and active fragments and variants thereof and methods of use | Apr 9, 2024 | Issued |
Array
(
[id] => 19497888
[patent_doc_number] => 20240336906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/627839
[patent_app_country] => US
[patent_app_date] => 2024-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18627839
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/627839 | DNA modifying enzymes and active fragments and variants thereof and methods of use | Apr 4, 2024 | Issued |
Array
(
[id] => 19464540
[patent_doc_number] => 20240318209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => GENETICALLY ENGINEERED BACTERIUM USING GLUCOSE AS SUBSTRATE FOR DE NOVO SYNTHESIS OF VANILLIN AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/627530
[patent_app_country] => US
[patent_app_date] => 2024-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18627530
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/627530 | GENETICALLY ENGINEERED BACTERIUM USING GLUCOSE AS SUBSTRATE FOR DE NOVO SYNTHESIS OF VANILLIN AND APPLICATION THEREOF | Apr 4, 2024 | Pending |
Array
(
[id] => 19512357
[patent_doc_number] => 20240344043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/628400
[patent_app_country] => US
[patent_app_date] => 2024-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18628400
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/628400 | DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE | Apr 4, 2024 | Abandoned |
Array
(
[id] => 19345504
[patent_doc_number] => 20240254467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/623704
[patent_app_country] => US
[patent_app_date] => 2024-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18623704
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/623704 | Nucleic acid molecules encoding DNA modifying enzymes and active fragments and variants thereof and compositions comprising the same | Mar 31, 2024 | Issued |
Array
(
[id] => 19318623
[patent_doc_number] => 20240240166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => DNase I Variants, Compositions, Methods, and Kits
[patent_app_type] => utility
[patent_app_number] => 18/621960
[patent_app_country] => US
[patent_app_date] => 2024-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18621960
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/621960 | DNase I Variants, Compositions, Methods, and Kits | Mar 28, 2024 | Pending |
Array
(
[id] => 20386779
[patent_doc_number] => 12486498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => L-arginine-glycine amidinotransferase and use thereof in the production of guanidinoacetic acid
[patent_app_type] => utility
[patent_app_number] => 18/415827
[patent_app_country] => US
[patent_app_date] => 2024-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 715
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18415827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/415827 | L-arginine-glycine amidinotransferase and use thereof in the production of guanidinoacetic acid | Jan 17, 2024 | Issued |
Array
(
[id] => 20386779
[patent_doc_number] => 12486498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => L-arginine-glycine amidinotransferase and use thereof in the production of guanidinoacetic acid
[patent_app_type] => utility
[patent_app_number] => 18/415827
[patent_app_country] => US
[patent_app_date] => 2024-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 715
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18415827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/415827 | L-arginine-glycine amidinotransferase and use thereof in the production of guanidinoacetic acid | Jan 17, 2024 | Issued |
Array
(
[id] => 19281871
[patent_doc_number] => 20240218345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => DECOLORIZING COMPOSITION INCLUDING DICYANDIAMIDE AND HYDROGEN PEROXIDE AND DECOLORIZING METHOD USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/402269
[patent_app_country] => US
[patent_app_date] => 2024-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18402269
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/402269 | DECOLORIZING COMPOSITION INCLUDING DICYANDIAMIDE AND HYDROGEN PEROXIDE AND DECOLORIZING METHOD USING THE SAME | Jan 1, 2024 | Pending |
Array
(
[id] => 19572152
[patent_doc_number] => 20240376444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => NON-CANONICAL LIPOPROTEINS WITH PROGRAMMABLE ASSEMBLY AND ARCHITECTURE
[patent_app_type] => utility
[patent_app_number] => 18/394536
[patent_app_country] => US
[patent_app_date] => 2023-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394536
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/394536 | NON-CANONICAL LIPOPROTEINS WITH PROGRAMMABLE ASSEMBLY AND ARCHITECTURE | Dec 21, 2023 | Pending |
Array
(
[id] => 20025257
[patent_doc_number] => 20250163479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => VISCOUS POLYHYDROXYALKANOATE, PREPARATION THEREOF, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/293690
[patent_app_country] => US
[patent_app_date] => 2023-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18293690
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/293690 | VISCOUS POLYHYDROXYALKANOATE, PREPARATION THEREOF, AND USE THEREOF | Nov 27, 2023 | Pending |
Array
(
[id] => 18988179
[patent_doc_number] => 20240060148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => SYSTEM AND METHOD FOR PRODUCING A SUGAR STREAM
[patent_app_type] => utility
[patent_app_number] => 18/501492
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 261
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501492
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/501492 | SYSTEM AND METHOD FOR PRODUCING A SUGAR STREAM | Nov 2, 2023 | Pending |
Array
(
[id] => 19020582
[patent_doc_number] => 20240076753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => SYSTEM AND METHOD FOR PRODUCING A SUGAR STREAM
[patent_app_type] => utility
[patent_app_number] => 18/501501
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501501
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/501501 | SYSTEM AND METHOD FOR PRODUCING A SUGAR STREAM | Nov 2, 2023 | Pending |
Array
(
[id] => 19234026
[patent_doc_number] => 20240191218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/497106
[patent_app_country] => US
[patent_app_date] => 2023-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497106
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/497106 | ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY | Oct 29, 2023 | Pending |
Array
(
[id] => 19300432
[patent_doc_number] => 20240229001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => NOVEL METALLOPROTEASES
[patent_app_type] => utility
[patent_app_number] => 18/487157
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 125531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18487157
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/487157 | NOVEL METALLOPROTEASES | Oct 15, 2023 | Pending |
Array
(
[id] => 19457919
[patent_doc_number] => 12098399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-24
[patent_title] => Compositions, systems, and methods for epigenetic regulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) gene expression
[patent_app_type] => utility
[patent_app_number] => 18/479758
[patent_app_country] => US
[patent_app_date] => 2023-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 29
[patent_no_of_words] => 76348
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18479758
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/479758 | Compositions, systems, and methods for epigenetic regulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) gene expression | Oct 1, 2023 | Issued |